| Market Cap | — | |
| Enterprise Value | — | |
| Revenue | — | — |
| Gross Profit | — | — |
| EBITDA | — | — |
| Net Income | £302.0M | — |
| Diluted EPS | £0.12 | — |
| Free Cash Flow | £778.0M | +100.5% |
| DPS (FY2025) | £0.20 |
| Trailing yield | — |
| Payout ratio | 159.6% |
| Growth streak | 2 yrs |
| 5y DPS growth | — |
| Fiscal year | DPS | YoY | Basis |
|---|---|---|---|
| FY20252025-12-31 | £0.20 | +2.0% | reported |
| FY20242024-12-31 | £0.20 | +2.0% | reported |
| FY20232023-12-31 | £0.20 | — | reported |
| Ratio | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend · 6y | vs own |
|---|---|---|---|---|---|---|---|---|
| ▾Margins | ||||||||
| NOPAT Margin | 8.29% | 0.62% | — | — | — | — | — | |
| Net Margin | 7.48% | 0.47% | — | — | — | — | — | |
| FCF Margin | 11.53% | 2.99% | — | — | — | — | — | |
| FCFF Margin | 12.31% | 3.10% | — | — | — | — | — | |
| OCF Margin | 16.93% | 7.33% | — | — | — | — | — | |
| Capex Intensity | 5.40% | 4.33% | — | — | — | — | — | |
| ▸Returns on Capital · 2 ratios | ||||||||
| ▸DuPont factors (ROE drivers) · 4 ratios | ||||||||
| ▸Earnings quality · 4 ratios | ||||||||
| ▸Liquidity & coverage · 1 ratios | ||||||||
| ▸Leverage · 2 ratios | ||||||||
| ▸Capital allocation · 5 ratios | ||||||||
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | £15.22B | £17.77B | -£8.54B | — | — | — |
| YoY % | +16.8% | |||||
| SG&A Expense | £2.73B | £2.80B | £2.81B | £2.24B | £2.57B | £2.73B |
| YoY % | +2.5% | +0.2% | -20.2% | +14.5% | +6.2% | |
| Interest Expense | £167.0M | £160.0M | £162.0M | £160.0M | £121.0M | £138.0M |
| YoY % | -4.2% | +1.2% | -1.2% | -24.4% | +14.0% | |
| Equity Method Income | -£55.0M | £81.0M | £38.0M | £23.0M | £24.0M | £17.0M |
| YoY % | -53.1% | -39.5% | +4.3% | -29.2% | ||
| Pretax Income | £1.60B | £788.0M | -£3.02B | £749.0M | £145.0M | £1.31B |
| YoY % | -50.9% | -80.6% | +803.4% | |||
| Income Tax | £463.0M | £696.0M | -£878.0M | £440.0M | £492.0M | £996.0M |
| YoY % | +50.3% | +11.8% | +102.4% | |||
| Net Income (incl. NCI) | £1.14B | £92.0M | -£2.06B | £309.0M | -£347.0M | £314.0M |
| YoY % | -91.9% | |||||
| Minority Interest (P&L) | £4.0M | £9.0M | £13.0M | £12.0M | £13.0M | £12.0M |
| YoY % | +125.0% | +44.4% | -7.7% | +8.3% | -7.7% | |
| Net Income | £1.14B | £83.0M | -£1.63B | £297.0M | -£360.0M | £302.0M |
| YoY % | -92.7% | |||||
| EPS (Basic) | £0.44 | £0.03 | -£0.66 | £0.13 | -£0.15 | £0.13 |
| YoY % | -92.6% | |||||
| EPS (Diluted) | £0.44 | £0.03 | -£0.66 | £0.12 | -£0.15 | £0.12 |
| YoY % | -92.7% | |||||
| Dividends Declared per Share | — | — | £20 | £0 | £0 | £0 |
| YoY % | -99.0% | +2.0% | +2.0% |
Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
